Report of the Council on Pharmacy and Chemistry
Iosaline is a rheumatism remedy for external application. In view of the misleading and unwarranted claims which are made for it, the Council voted that Iosaline be refused recognition and recommended publication of the Committee’s report which appears below.
W. A. Puckner, Secretary.
COMMITTEE’S REPORT
The following sweeping but rather indefinite claims are made for Iosaline.
“Iosaline is a penetrator and overcomes the objectionable escharotic properties of Iodine; it is readily absorbed and may be used without discomfort or discoloration.”
“The strong analgesic properties of Iosaline make it especially useful in controlling pain in cases of Neuralgia, Rheumatism, Gout, and Arthritis Deformans.”
As there are few, if any, known iodin compounds which are “readily absorbed” through the skin and which will not at the same time produce discoloration or discomfort, it was thought worth while to take up the examination of Iosaline. The results of this examination are reported by the Chemical Laboratory of the Association as follows:
Laboratory Report:—Iosaline is advertised by the Iosaline Company of New York, as a remedy for the treatment by external application, of rheumatism, gout, neuralgia, pneumonia and numerous other diseases. Concerning its composition the following statements are made: